Hi Harry, nice to see you on the board! Hope you and your wife are hanging in these days! How is she doing?

Yeah, I suppose you raise a good point that I hadn't thought of. Although he is very supportive of LDN for MS, and attends the LDN conference to sing it's praises, I guess he could have said more about MS specifically in this interview.

I've talked to Skip on the phone, but because he is SO approachable/helpful, I hadn't really considered him a big-wig in the pharmaceutical world. My compounding pharmacist in Canada is also very well respected in his field, so it's good to know we have this kind of expertise on our side anyway. I liked hearing that part of the interview (his credentials), combined with his theories on how the drug might be working in our bodies. Personally, that adds credence/a sense of comfort for the use of LDN with whatever ailment.

He's the largest compounder of LDN in the US, and he is intimately aware of the effects of this drug on his patients/customers. Perhaps, in his experience he's seen that LDN works wonders on so many ailments, so he wants to ensure that message gets out (not just about MS).

I enjoyed the interview from "the big picture" point of view.

Cherie